Sales & Support: +44 (0)1223 316 855


The Wantai SARS-CoV-2 lgM ELISA from Beijing Wantai Biological Pharmacy qualitatively detects lgM-class antibodies to SARS-CoV-2 in human serum and plasma. This enzyme-linked immunosorbent assay is for the testing of patients suspected of recent infection with the SARS-CoV-2 virus.

Performance evaluationsSARS-CoV-2 IgM ELISA
Medizinische Universität Wien
Medizinische Universität Wien in Austria reported a kit sensitivity of 92% (6 ~10 days) to 100% after day 11 post disease onset and a specificity of 97%.
Medizinische Universität Wien article
Dutch Serology Taskforce
In the Netherlands, data collection and reporting by the Dutch Serology Taskforce, part of the Dutch National Testing Capacity Coordination Structure, showed kit sensitivity of 91.9% for samples collected >14 days after the onset of illness
Dutch Serology Taskforce report

UK Government COVID-19 testing guidance
The UK Government’s guidance regarding the use of the COVID-19 diagnostic assays can be found here

The test should not be used as the sole basis for diagnosis.


Note: product availability depends on country - see product detail page.

Details Cat number & supplier Size Price
SARS-CoV-2 IgM ELISA (CE-IVD) WS-1196 · Beijing Wantai Biological Pharmacy
Beijing Wantai Biological Pharmacy
96 wells POA
96 wells